A Renal Safety Checkpoint for Early High Intensity Statin Therapy in Critically Ill Patients With Acute Coronary Syndrome: A Multidatabase Target Trial Emulation

The study emulated an active-comparator target trial across MIMIC-IV, eICU, and MIMIC-III, focusing on critically ill adults with ACS. The proposed safety checkpoint integrates kidney function, hemodynamic parameters, and interacting medications to guide statin intensity decisions in the ICU. This is clinically relevant because ICU prescribing often occurs amid changing renal perfusion and polypharmacy, yet data on optimal statin dosing in this context are limited. The findings could inform more nuanced early statin protocols, potentially reducing renal injury while preserving cardiovascular benefits. Further validation and prospective testing would be needed before clinical implementation.